Treatment monitoring with 18F-FDG PET in metastatic thymoma after 90Y-Dotatoc and selective internal radiation treatment (SIRT)

Hellenic Journal of Nuclear Medicine

Volumn 12, Issue 3, 2009, Pages

  Vasamiliette, Julie ^a   Hohenberger, Peter ^b   Schoenberg, Stefan ^b   Diehl, Steffen ^b   Dinter, Dietmar J ^b   Marx, Alexander ^b   Stroebel, Philipp ^b   Strauss, Ludwig G ^a   Dimitrakopoulou Strauss, Antonia ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

68Ga dotatoc; 90Y dotatoc; Selective internal radiation treatment; Tyrosine kinase inhibitors; Unresectable thymoma

Indexed keywords

1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID TYROSINE 3 OCTREOTIDE GA 68; 1,4,7,10 TETRAAZACYCLODODECANE 1,4,7,10 TETRAACETIC ACID TYROSINE 3 OCTREOTIDE Y 90; FLUORODEOXYGLUCOSE F 18; IMATINIB; RADIOPHARMACEUTICAL AGENT; SOMATOSTATIN RECEPTOR 2; SUNITINIB; UNCLASSIFIED DRUG; YTTRIUM 90; DIAGNOSTIC AGENT;

ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CASE REPORT; DRUG METABOLISM; DRUG UPTAKE; HUMAN; HUMAN TISSUE; LIVER; LIVER BIOPSY; LIVER METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PROTEIN EXPRESSION; THYMOMA; TUMOR VOLUME; LIVER TUMOR; METASTASIS; METHODOLOGY; PROGNOSIS; SCINTISCANNING; THYROID TUMOR; TREATMENT OUTCOME;

ADULT; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER NEOPLASMS; MALE; POSITRON-EMISSION TOMOGRAPHY; PROGNOSIS; RADIOPHARMACEUTICALS; THYMOMA; THYROID NEOPLASMS; TREATMENT OUTCOME;

EID: 72249116467     PISSN: 11081430     EISSN: 17905427     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Ströbel P, Hartmann M, Jakob A et al. Thymic Carcinoma with Overexpression of Mutated KIT and the Response to Imatinib. N Engl J Med 2004; 350: 2625-2626. (Pubitemid 38758557)
2. Miederer M, Seidel S, Buck A et al. Correlation of immunohistopathological expression of somatostatin receptor 2 with standardized uptake values in 68Ga-DOTATOC PET/CT. Eur J Med Mol Imaging 2009; 36: 48-52.
3. 90Y-Dotatoc. Hell J Nucl Med 2009; 12: 161-164.
4. 90Y-DOTATOC therapy for down-sizing synchronous bilobular hepatic metastases from a neuroendocrine pancreatic tumor. Langenbecks Arch Surg. 2009; DOI 10.1007/s00423-009-0520-x.
5. 90Y microsphere selective internal radiation treatment for tumor downsizing and future liver remnant recruitment: a novel approach to improving the safety of major hepatic resections. World J Surg Oncol 2009; 7:6.
6. Moroz P, Anderson JE, Van Hazel G, Gray BN. Effect of selective radiation therapy and hepatic arterial chemotherapy on normal liver volume and spleen volume. J Surg Oncol 2001; 78: 249-252. (Pubitemid 33097055)
7. 18F-FDG uptake and tumor size in PET/CT. Eur J Nucl Med Mol Imaging 2005; 32: 778-787. (Pubitemid 41125420)
8. 90Y SIR-spheres: an evaluation with PET. Hepatogastroenterology 2007; 54: 910-912. (Pubitemid 46903751)
9. Dierckx R, Maes A, Peeters M, Van de Wiele C. FDG PET for monitoring response to local and locoregional therapy in HCC and liver metastases. Q J Nucl Med Mol Imaging 2009; 53: 336-342.
10. Torizuka T, Tamaki N, Inokuma T et al. Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy. J Nucl Med 1994; 35: 1965-1999. (Pubitemid 24376612)
11. 90Y microspheres: value of FDG PET versus computed tomography. Nucl Med Commun 2007; 28: 15-20. (Pubitemid 44949683)
12. Anovazzi A, Peeters M, Maenhout A et al. 18-Fluorodesoxyglucose positrone emission tomography in non-endocrine neoplastic disorders of the gastrointestinal tract. Gastroenterology 2003; 125: 1235-1245.
13. 18F]fluodeoxyglucose positron emission tomographic imaging. J Vasc Interv Radiol 2005; 16: 1101-1106. (Pubitemid 41177123)
14. Pöpped G, Helmberger T, Münzing W et al. Selective internal radiation therapy with SIR-Spheres in patients with nonresectable liver tumors. Cancer Biother Radiopharm 2005; 20: 200-208. (Pubitemid 40696103)
15. Wong CY, Savin M, Sherpa KM et al. Regional yttrium-90 microsphere treatment of surgically unresectable and chemotherapy-refractory metastasic liver carcinoma. Cancer Biother Radiopharm 2006; 21: 305-313. (Pubitemid 44689684)